Treatment methods and effect of glucose metabolit disorders after liver transplantation
10.3760/cma.j.issn.1674-635X.2012.04.002
- VernacularTitle:肝移植后糖代谢紊乱的治疗方法和效果
- Author:
Yujian NIU
;
Hongyu WANG
;
Chun XU
;
Xiaojun LIU
;
Li LI
;
Shan SHAN
- Publication Type:Journal Article
- Keywords:
Liver transplantation;
Post-transplantation diabetes mellitus;
Glargine;
Repaglinide;
Efficacy;
Safety;
Dietary control
- From:
Chinese Journal of Clinical Nutrition
2012;20(4):200-203
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the efficacy and safety of glargine combined with repaglinide in the treatment of post-transplantation diabetes mellitus(PTDM).Methods PTDM patients who were treated in our hospital from Jan 1,2010 to Dec 31,2010 were enrolled in this study.They were administrated with glargine combined with repaglinide for 6 months,and their glucose level,hepatic and renal function indicators,and tacrolimus concentration were examined at baseline and 1,3,and 6 months after treatment.Results Totally 44 patients were included and given dietary control.Three cases were not given any hypoglycemic drugs,7 were administrated with glargine only,30 cases received glargine combined with repaglinide therapy,and 4 cases required intensive insulin therapy.All the patients achieved satisfactory glycemic control.The hepatic function,renal function,and serum tacrolimus concentration showed no significant change before and after repaglinide therapy(P ＞ 0.05).Five hypoglycemic events were recorded during the treatment,in which the lowest blood glucose level was 3.7 mmol/L.No severe hypoglycemia happened.Conclusion On the basis of dietary control,glargine combined with repaglinide provides a safe and effective therapy for PTDM.
